Activation of SIRT1/AMPK can improve liver injury in NAFLD by regulating lipid metabolism [47,48], relieving inflammation [49], and attenuating endoplasmic reticulum stress and insulin resistance [50]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.